CBD Directly Activated Glycine Receptors Involved in Pain Processing
CBD both modulated and directly activated glycine receptors in the spinal cord at micromolar concentrations, providing a potential mechanism for its anti-inflammatory and pain-relieving effects.
Quick Facts
What This Study Found
Researchers investigated whether CBD interacts with glycine receptors, which are the main inhibitory neurotransmitter receptors in the adult spinal cord and are important for pain processing.
CBD showed a positive allosteric modulating effect on alpha1 and alpha1-beta glycine receptors at low micromolar concentrations (EC50 of 12.3 and 18.1 micromolar). This means CBD enhanced the receptors' response to their natural activator.
At higher concentrations (above 100 micromolar), CBD directly activated the receptors independently (EC50 of 132.4 and 144.3 micromolar).
Since loss of glycinergic inhibition in the spinal cord is a key mechanism in the development of chronic pain following inflammation or nerve injury, CBD's ability to restore or enhance glycine receptor function could explain some of its pain-relieving properties through a non-cannabinoid receptor mechanism.
Key Numbers
Allosteric modulation EC50: alpha1 = 12.3 micromolar, alpha1-beta = 18.1 micromolar. Direct activation EC50: alpha1 = 132.4 micromolar, alpha1-beta = 144.3 micromolar.
How They Did This
Whole-cell patch clamp electrophysiology on cells expressing alpha1 or alpha1-beta glycine receptors. CBD effects were measured as changes in glycine-evoked currents (allosteric modulation) and as direct current induction (direct activation).
Why This Research Matters
This study identified a specific non-cannabinoid receptor mechanism for CBD's pain effects. Since glycine receptor dysfunction is implicated in chronic pain development, CBD's ability to enhance glycinergic transmission provides a mechanistic explanation for clinical pain relief.
The Bigger Picture
This study added glycine receptors to the growing list of non-cannabinoid targets through which CBD exerts pharmacological effects. The glycine receptor mechanism is particularly relevant for understanding CBD's analgesic properties in chronic and inflammatory pain.
What This Study Doesn't Tell Us
In vitro electrophysiology on expressed receptors may not reflect in vivo conditions. The concentrations needed for direct activation (>100 micromolar) may not be achievable in the spinal cord with typical CBD dosing. Only two receptor subtypes were tested.
Questions This Raises
- ?Are spinal glycine receptor concentrations of CBD achievable with therapeutic dosing?
- ?Does the allosteric modulation (at lower concentrations) contribute more to pain relief than direct activation?
Trust & Context
- Key Stat:
- CBD enhanced glycine receptor function at 12-18 micromolar (allosteric modulation)
- Evidence Grade:
- This is an in vitro electrophysiology study providing preliminary mechanistic evidence. The clinical significance depends on whether therapeutic CBD concentrations reach the relevant levels.
- Study Age:
- Published in 2009. CBD-glycine receptor interactions have been further characterized in subsequent studies, confirming this as a relevant target.
- Original Title:
- The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.
- Published In:
- Pharmacology, 83(4), 217-22 (2009)
- Authors:
- Ahrens, Jörg(2), Demir, Reyhan(2), Leuwer, Martin(2), de la Roche, Jeanne, Krampfl, Klaus, Foadi, Nilufar, Karst, Matthias, Haeseler, Gertrud
- Database ID:
- RTHC-00342
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What are glycine receptors?
Glycine receptors are the main inhibitory neurotransmitter receptors in the spinal cord. They help dampen pain signals. When they don't work properly (as in chronic pain conditions), pain signals are amplified.
Is this why CBD helps with pain?
It may be one mechanism among several. CBD interacts with many molecular targets. The glycine receptor mechanism is particularly relevant for spinal cord-level pain processing, where CBD could help restore the inhibitory tone that is lost in chronic pain.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00342APA
Ahrens, Jörg; Demir, Reyhan; Leuwer, Martin; de la Roche, Jeanne; Krampfl, Klaus; Foadi, Nilufar; Karst, Matthias; Haeseler, Gertrud. (2009). The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.. Pharmacology, 83(4), 217-22. https://doi.org/10.1159/000201556
MLA
Ahrens, Jörg, et al. "The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function.." Pharmacology, 2009. https://doi.org/10.1159/000201556
RethinkTHC
RethinkTHC Research Database. "The nonpsychotropic cannabinoid cannabidiol modulates and di..." RTHC-00342. Retrieved from https://rethinkthc.com/research/ahrens-2009-the-nonpsychotropic-cannabinoid-cannabidiol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.